Page last updated: 2024-10-17

aminocaproic acid and Pulmonary Hypertension

aminocaproic acid has been researched along with Pulmonary Hypertension in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, JR1
Abrams, J1
Frazier, OH1
Radovancevic, R1
Radovancevic, B1
Bracey, AW1
Kindo, MJ1
Gregoric, ID1

Other Studies

1 other study available for aminocaproic acid and Pulmonary Hypertension

ArticleYear
Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy.
    The Journal of thoracic and cardiovascular surgery, 2006, Volume: 131, Issue:5

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Arterioles; Capillaries; Cardiac Surgi

2006